Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 08:00 ET

Express News | Praxis Precision Medicines : Sales Agreement Prospectus Covering Offering up to $250 Mln of Common Stock That May Be Issued From Time to Time

ReutersDec 23, 2024 16:15 ET

Express News | Praxis Precision Medicines Inc Files for Mixed Shelf- SEC Filing

ReutersDec 23, 2024 16:14 ET

Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Moomoo NewsDec 20, 2024 13:31 ET · Ratings

Praxis Precision Medicines (PRAX) Gets a Buy From Truist Financial

TipRanksDec 20, 2024 12:39 ET · Ratings

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome; Praxis Plans To Initiate An All-DEE Trial (EMERALD), Inclusive Of Dravet Syndrome, In 1H2025

BenzingaDec 18, 2024 08:14 ET